Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1996
10/16/1996CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/16/1996CN1033003C Method of preparing toxid
10/15/1996US5565551 Non-azo naphthalimide dyes and uses for same
10/15/1996US5565550 Antibodies to ICAM-2, and fragments thereof
10/15/1996US5565549 Retroviruse, aids
10/15/1996US5565548 Peptide having sequence of protective antibody-eliciting epitope and having mercapto groups linked to carrier comprising lipid vesicle containing amino moiety activated by polyaldehyde and cysteine
10/15/1996US5565319 Enzyme-linked immunosorbent assay comprising solid phase coated with viral antigen to which antibodies in sample will bind, detectable label conjugate which will bind to antibodies
10/15/1996US5565209 Adjuvant mixture
10/15/1996US5565205 Immunizing a swine against infection
10/15/1996US5565204 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
10/15/1996US5565203 Hepatitis A virus in a reconstituted influenza virosome and use as a vaccine
10/15/1996US5565202 Low enhancement serotype 2 vaccine for marek's disease
10/15/1996US5565198 Zona pellucida as a growth stimulant
10/10/1996WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031604A1 Antibodies for the detection of hla-g
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031535A1 Process for purifying filamentary haemagglutinin and pertussis toxin
10/10/1996WO1996031496A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996031237A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996WO1996031236A1 Chlamydia vaccines
10/10/1996WO1996031235A1 Composition for inducing a mucosal immune response
10/10/1996WO1996031224A1 Immunosuppressant
10/10/1996WO1996031186A2 Product and method for preventing respiratory virus infection
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996WO1996012009A3 Methods for engineering antigen-presenting cells
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217297A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996CA2217154A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
10/10/1996CA2216092A1 Expression library immunization
10/10/1996CA2215978A1 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/10/1996CA2212562A1 Product and method for preventing respiratory virus infection
10/10/1996CA2192473A1 Composition for inducing a mucosal immune response
10/09/1996EP0736770A2 An immunoreactive conjugate, method for its preparation, antibodies to said conjugate and a pharmaceutical composition and diagnostic device containing them
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736180A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
10/09/1996EP0736098A1 Mycobacteria virulence factors and a method for their identification
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736089A1 Thermostable varicella zoster virus
10/09/1996EP0736088A1 Monoclonal antibodies to hepatitis e virus and methods for using same
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0735898A1 Vaccines
10/09/1996EP0735897A1 "prophylaxis of allergic disease"
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1133013A Vaccin respiratory syncytial viral vaccines
10/08/1996US5563123 Chimeric proteins
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5563038 Detergent has lipophilic, hydrophilic segments
10/08/1996US5563032 Mosaic polypeptide and methods for detecting the hepatitis E virus
10/08/1996US5562910 Vaccine compositions and method for enhancing an immune response
10/08/1996US5562909 Phosphazene polyelectrolytes as immunoadjuvants
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/08/1996US5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
10/08/1996US5562902 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
10/08/1996CA1338632C Cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/07/1996CA2146481A1 Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization
10/03/1996WO1996030544A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996WO1996030527A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996WO1996030523A2 Antigen presentation system based on retrovirus-like particles
10/03/1996WO1996030521A2 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid
10/03/1996WO1996030520A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
10/03/1996WO1996030519A1 Haemophilus adhesion proteins
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030387A1 Novel human cytomegalovirus dna sequences
10/03/1996WO1996030057A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
10/03/1996WO1996030053A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996WO1996030046A1 Vascular endothelial cell growth factor antagonists
10/03/1996WO1996030045A1 Vaccine for the immunoprophylaxis of the infection from feline immunodeficiency virus in the domestic cat
10/03/1996WO1996030044A1 Carbohydrate-based vaccine and diagnostic reagent for trichinosis
10/03/1996WO1996030043A1 Treatment for verotoxin-producing escherichia coli
10/03/1996WO1996030039A1 Method for enhancing the antibody response to specific antigens with interleukin-10
10/03/1996WO1996030036A1 Compounds and compositions for delivering active agents
10/03/1996WO1996030030A1 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
10/03/1996WO1996026285A3 Methods and compositions for administering gene therapy vectors
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2805588A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2770491A1 Hapten-carrier conjegates for use in drug-abuse therapy
10/03/1996CA2754887A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2588767A1 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996CA2218601A1 Treatment for verotoxin-producing escherichia coli
10/03/1996CA2216835A1 Human g-protein coupled receptors
10/03/1996CA2216807A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996CA2216612A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors
10/03/1996CA2216292A1 Haemophilus adhesion proteins
10/03/1996CA2215968A1 Method for enhancing the antibody response to specific antigens with interleukin-10
10/03/1996CA2215836A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/02/1996EP0734737A2 Particle delivery of particularly therapeutic powdered agents
1 ... 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 ... 1823